Paolo Sgargi
University of Parma(IT)
Publications by Year
Research Areas
Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer, Advanced Breast Cancer Therapies
Most-Cited Works
- → The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998–2012(2018)79 cited
- → Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy(2017)68 cited
- → Thyroid cancer incidence by histological type and related variants in a mildly iodine‐deficient area of Northern Italy, 1998 to 2009(2012)46 cited
- → Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer(2016)28 cited
- → Human Epidermal Growth Factor Receptor 2 Status and Interval Breast Cancer in a Population-Based Cancer Registry Study(2012)28 cited
- → Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study(2023)19 cited
- → The changing distribution and survival of colorectal carcinoma: an epidemiological study in an area of northern Italy(2005)18 cited
- → Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer(2022)17 cited
- → Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers(2015)13 cited
- → Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series(2019)9 cited